Hematology Week 2: Introduction to Thrombophilia Flashcards
Virchow’s Triad
3 listed

- Alteration of blood flow
- Endothelial injury
- Hypercoagulable state (inherent/acquired)
VTE AKA
Venous Thromboembolism
Thrombosis High-Risk Patients
3 listed
- Males
- >55
- recently hospitalized
DVT AKA
Deep Venous Thrombosis
circulatory stasis involves
alteration of blood flow
Circulatory stasis: Things that contribute to a clot in arteries
Turbulence
Circulatory stasis: Things that contribute to a clot in venous
Stasis
Circulatory stasis
Arterial: turbulence
Venous: Stasis

Alteration of blood flow consequences
Disruption of laminar flow via stasis or turbulence
- allows platelets to interact with endothelium
- activates endothelium
- prolongs exposure of activated clotting factors

Common Causes of Alteration of blood flow in the arteries/cardiac/aortic
3 listed
- Aneurysms
- Dilated atrium
- Ulcerated atherosclerotic plaques

Causes of Altered blood flow in the venous system
9 listed
- Prolonged immobilization
- Paget-Schroetter syndrome axial or subclavian vein can be compressed
- Clot in iliac veins (pregnancy) left iliac vein is compressed by the right iliac artery

Common Causes of Hyperviscosity
3 listed
- polycythemia (primary, secondary)
- Sickle Cell Anemia
- Increased plasma proteins

Causes of arterial endothelial injury
12 listed
commonly affected due to high flow rates

Indications for inheritable Hypercoagulable States
5 listed
age <40
unprovoked thrombosis
FHx of thrombosis
Thrombosis at an unusual site

Contraindicators of inherited hypercoagulable states
NOT associated with arterial thrombosis (Stroke, TIA, MI, etc)
Inherited hypercoagulability conditions
5 listed
- Factor V Leiden
- Factor II hyperprothrombinemia
- AT deficiency
- Protein C deficiency
- Protein S deficiency
Procoagulant gains of function conditions
2 listed
- Factor V Leiden
- Factor II hyperprothrombinemia

inherited conditions with a weaker risk of VTE
2 listed
- Factor V Leiden
- Factor II hyperprothrombinemia
Factor V Leiden Genetic inheritance pattern
- Autosomal Dominant
- can be traced back to a single mutational event 25k years ago
accounts for half of all heritable thrombophilias
Factor V Leiden

Found in 12-18% of all patients with VTE
Factor V Leiden

Factor V Leiden subtype increased risks
Heterozygotes patients with a NON-O BLOOD TYPE have more FVIII and have 2-4x more risk of VTE
Risk of recurrence of VTE with Factor V Leiden
Negligible recurrence risk
Risks of heterozygotes of Factor V Leiden
5% will have VTE
non-O blood type has increased risks
What does Factor 5 do?
factor 5 associated with factor 10 to link the intrinsic and extrinsic pathways

Factor V in Factor V Leiden
Factor V is less susceptible to the inhibition of the anticoagulant protein Protein C
Factor V Leiden Etiology
arginine to glutamine substitution at R506

Factor II Hyperprothrominemia Genetic inheritance and consequences
- Autosomal dominant
- nearly exclusively caucasian
- 3-4 fold increased risk of thrombosis
Factor II Hyperprothrombinemia Genetics
Autosomal Dominant
Factor II Hyperprothrombinemia VTE recurrence risk
Negligible recurrence risk
Factor II Hyperprothrombinemia Pathophysiology
gain of function mutation in 3’ unstranslated region resulting in increased plasma prothrombin levels by 25%

Factor II Hyperprothrombinemia gene
prothrombin 20210A untranslated region causing high efficiency mRNA
More rare inherited conditions of hypercoagulability
3 listed
- AT Deficiency
- Protein C deficiency
- Protein S Deficiency

inherited conditions of hypercoagulability with greater risk of VTE
3 listed
- At Deficiency
- Protein C Deficiency
- Protein S Deficiency
Inherited conditions of hypercoagulability that are measured by activity or antigen levels
3 listed
At Deficiency
Protein C Deficiency
Protein S Deficiency
Protein C Deficiency Genetics
Autosomal Dominant >160 mutations
Protein C Deficiency epidemiology
3 listed
- .2-.5% of population
- 2-5% of all VTE patients
- initial VTE episode is spontaneous in 2/3 of patients
Protein C deficiency Caveats
- Homozygotes are rare but typically fatal (born with purpura fulminans)
- Heterozygotes Risk of warfarin skin necrosis because it is a vitamin K antagonist
Protein S deficiency Genetics
Autosomal Dominant
Protein S deficiency epidemiology
rare <1% of population
most difficult to Dx Inherited condition of hypercoagulability
Protein S deficiency
Protein S deficiency Homozygotes
Rare but typically fatal (born with purpura fulminans
Protein S deficiency Caveat
- can be a physiologic phenomenon during pregnancy
- Risk of Warfarin skin necrosis
Protein S deficiency pathophysiology
Protein S is a cofactor for Protein C to put the brakes on Factor V
Antithrombin Deficiency Genetics
Autosomal Dominant (mostly)
Antithrombin Deficiency Epidemiology
0.02% of population
1% of all VTE cases particularly in pregnancy
Half of affected patients have spontaneous VTE
Much higher o
Antithrombin Deficiency Acquired form
Nephrotic Syndrome (more common than Antithrombin Deficiency)
Which inherited hypercoagulable condition carries the highest risk for VTE?
Antithrombin Deficiency
Antithrombin Function
Antithrombin inhibits thrombin

Inherited Conditions of hypercoagulability association with pregnancy morbidity
No significant association
Inherited Conditions of hypercoagulability association with arterial thrombosis
No significant association
Heritable thrombophilias Overview

Clots usually occur in a vein where?
Around a valve

Tissue Factor can also be expressed on________ to contribute to _________
White Cells, clotting
Neutrophils NETs can contribute to?
Clotting
Hypoxia in valve areas can contribute to?
Clotting
Treatment of unprovoked clots
nowhere does thrombophilia affect treatment decisions, if a patient has a clot they have a pretty high risk to have another clot regardless of how they got it

Acquired Hypercoagulable Conditions
5 listed

Acquired Hypercoagulable Conditions Arterial Thrombosis possible
- Heparin-induced thrombocytopenia
- Antiphospholipid syndrome
- Cancer
Heparin-induced Thrombocytopenia
1/5000 patients typically using unfractionated heparin and cardiac surgery
Heparin-induced thrombocytopenia pathophysiology
- prothrombotic, potentially fatal complication of heparin treatment
- demonstrate anti-PF4/heparin antibodies
Heparin-induced thrombocytopenia mechanism
positively charged PF4 molecules are stored in alpha granules of platelet interact with negatively charged heparin polysaccharide causing a conformational change of the PF4 molecule that is immunogenic quickly developing IgG antibodies within 4-5 days
antibodies complex with platelets which have Fc receptors which cause antibody activation of platelets which release more PF4 causing a cycle

HIT AKA
Heparin-induced Thrombocytopenia
HIT Treatment
stop heparin and put them on another anticoagulant
Antiphospholipid Syndrome in vitro vs in vivo
- autoimmune hypercoagulable state
- causes prolongation of PTT in vitro
- In vivo causes clotting

Antiphospholipid syndrome antibody to
ß2GP1

Antiphospholipid syndrome pathophysiology
ß2GP1 conformational change can become immunogenic which can upregulate complement activity, upregulating endothelial proteins, increasing tissue factor expression, activates platelets, interferes with trophoblasts (pregnancy morbidity)
Antiphospholipid syndrome how is it diagnosed
Clinicopathologic diagnosis
patient with thrombotic episode or a pregnancy morbidity by the loss of pregnancy after 10 wks gestation or lost 3 pregnancies before 10 weeks gestation, preterm labor before 34 weeks gestations eclampsia or preeclampsia

Antiphospholipid syndrome Transiency
need to prove that the antibodies are persistent because 10% of healthy subjects need to have transient antibodies 12 weeks apart the same type of the 3

Antiphospholipid syndrome clinical presentation
3 listed
DVT in lower extremity but PE is less common
arterial thrombosis
microvascular clotting: least common and the most deadly woul be called catastrophic Antiphospholipid syndrome)

Catastrophic Antiphospholipid syndrome
microvascular clotting in Antiphospholipid syndrome

Cancer and thrombosis epidemiology

Hypercoagulability Estrogen and hormone replacement therapy
- also true for testosterone
- confers increased risk for thrombosis
- most risk in the first year

Hypercoagulability and pregnancy
can increase risk of clot by 10x

Hypercoagulability and pregnancy how many thromosis occur post partum?
1/3
Hypercoagulability and pregnancy thrombosis prevalence
0.86 per 1000 deliveries
Hypercoagulability and pregnancy mechanism of increased risk
5 listed
- decreased protein S levels
- Increased fibrinogen and prothrombin
- increased estrogen
- impaired fibrinolysis
- vascular congestion

Symptoms of DVT
4 listed
- swelling
- pain
- redness
- heat

Symptoms for pulmonary embolism
5 listed
tachypnea is the most reliable symptom

Symptoms for pulmonary embolism most reliable symptom
Tachypnea
Symptoms for pulmonary embolism most common symptoms
chest pain and tachypnea
pulmonary embolism picture

D-Dimer Test
best test for thrombosis

Clinical and pathophysiologic aspects of thrombosis
5 listed

How are D-dimers formed?

d-dimer is only detectable if?
Factor XIIIa has crosslinked fibrin
Arterial vs venous thrombosis

Arterial vs venous thrombosis

Clot in iliac veins (pregnancy) the ____________ is compressed by the ________________.
left iliac vein is compressed by the right iliac artery
Clotting in Paget–Schroetter
axial or subclavian vein can be compressed